Regulations.gov document
Exhibit A Kevin Riley Citi on the Impact of Biosimilars and Losing $360 Billion in…
Supporting & Related Material · FDA-2015-P-4529 · posted Dec 8, 2015
Key facts
| Document ID | FDA-2015-P-4529-0003 |
|---|---|
| Title | Exhibit A Kevin Riley Citi on the Impact of Biosimilars and Losing $360 Billion in Revenues re: Citizen Petition from UAW Retiree Medical Benefits Trust |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2015-P-4529 |
| Posted | Dec 8, 2015 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: